Israel's OurCrowd leads $12 million investment to develop COVID-19 vaccine

Israeli venture investing platform OurCrowd said on Wednesday it would lead a $12 million investment in the newly formed MigVax Corp, which plans to develop a novel COVID-19 vaccine.